Effects of Dexmedetomidine on the Localization of α2A-Adrenergic and Imidazoline Receptors in Mouse Testis

Dexmedetomidine (DEX) used for sedation was reported to have organ-protecting effects in ischemia–reperfusion injury model animals. However, no testicular cell-protecting effect was observed with DEX treatment. The effects of DEX on a normal testis in vivo have not been reported. Therefore, DEX was...

Full description

Bibliographic Details
Published in:	Applied Sciences
Main Authors:	Hayato Nomura, Hayato Terayama, Daisuke Kiyoshima, Ning Qu, Kosuke Shirose, Shuhei Tetsu, Shogo Hayashi, Kou Sakabe, Takeshi Suzuki
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	α2A-adrenergic receptor dexmedetomidine imidazoline receptor mouse testis
Online Access:	https://www.mdpi.com/2076-3417/12/20/10409

Similar Items

Modelling of chromatographic and electrophoretic behaviour of imidazoline and alpha adrenergic receptors ligands under different acid-base conditions
by: Slavica Oljacic, et al.
Published: (2024-05-01)

Dexmedetomidine activates the PKA/CREB pathway and inhibits proinflammatory factor expression through β2 adrenergic receptors
by: Baocheng Zhang, et al.
Published: (2024-02-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

Dexmedetomidine modulates neuronal activity of horizontal limbs of diagonal band via α2 adrenergic receptor in mice
by: Xia-wei Zhang, et al.
Published: (2023-10-01)

Nonclassical cardiovascular effects of imidazoline receptor agonists
by: Yulia V. Stepenko, et al.
Published: (2025-09-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Molecular Modeling, Synthesis, and Antihyperglycemic Activity of the New Benzimidazole Derivatives – Imidazoline Receptor Agonists
by: Martynov A, et al.
Published: (2024-04-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Research progress in the central nervous system mechanism of dexmedetomidine
by: SONG Yifan, et al.
Published: (2024-05-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
by: András Érszegi, et al.
Published: (2024-06-01)

Dexmedetomidine preconditioning attenuates ferroptosis in myocardial ischemia-reperfusion injury via α2 adrenergic receptor activation
by: Mingling Wang, et al.
Published: (2024-11-01)

Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors
by: Marie Amitani, et al.
Published: (2015-08-01)

Effects of the number of imidazoline ring and the length of alkyl group chain of imidazoline derivatives on corrosion inhibition of carbon steel in HCl solution: Molecular simulation and experimental validation
by: Chenfeng Zhang, et al.
Published: (2022-12-01)

Thymoquinone activates imidazoline receptor to enhance glucagon-like peptide-1 secretion in diabetic rats
by: Shu Ping Lee, et al.
Published: (2019-07-01)

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis
by: Comi E, et al.
Published: (2017-05-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

Agmatine Mitigates Diabetes-Related Memory Loss in Female Mice by Targeting I<sub>2</sub>/I<sub>3</sub> Imidazoline Receptors and Enhancing Brain Antioxidant Defenses
by: Luis E. Cobos-Puc, et al.
Published: (2025-07-01)

Alpha‐2a adrenergic receptor activation in genetic absence epilepsy: An absence status model?
by: Melis Yavuz, et al.
Published: (2024-04-01)

The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study
by: Yoon Ji Choi, et al.
Published: (2022-03-01)

New Aspects of 2-Adrenergic Agonists
by: Touseef Sayyar
Published: (2015-12-01)

A comparative study to evaluate the efficacy of intrathecal dexmedetomidine and intrathecal clonidine as an adjuvant to hyperbaric 0.75% ropivacaine in patients undergoing orthopedic surgery under spinal anaesthesia
by: Sumedha Mehta, et al.
Published: (2025-01-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

Dexmedetomidine in cardiac surgery: Emphasis on interleukin-18 signaling pathway
by: Bassim Mohammed Jabbar Hatemi, et al.
Published: (2025-02-01)

Clinically relevant concentrations of dexmedetomidine may reduce oxytocin-induced myometrium contractions in pregnant rats
by: Dong Joon Kim, et al.
Published: (2020-10-01)

DEXMEDETOMIDINE TOXIC INFLUENCE ON ANMAL ORGANISMS BY PROLONGED APPLICATION ON THE RESEARCH EXAMPLE ON WHITE MICE
by: Omelianenko Oleksandr Yevheniiovych
Published: (2021-12-01)

Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem
by: E. I. Baranova, et al.
Published: (2025-03-01)

The role of adrenergic receptor polymorphisms in heart failure
by: A. Biolo, et al.
Published: (2006-10-01)

Effects of Alkoxylated Imidazoline Rust Inhibitors on the Properties of Reinforced Concrete
by: WANG Yaru, YANG Zhensheng, YANG Jian, LI Zhuangzhuang, SHI Nana, CHEN Long
Published: (2024-10-01)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
by: Annika M. A. Berends, et al.
Published: (2022-04-01)

β-Adrenergic receptor signaling in cardiac function and heart failure
by: Aasakiran Madamanchi
Published: (2020-12-01)

The efficacy and safety of mirabegron and α-adrenergic receptor antagonist in the treatment of distal ureteral stones: a systematic review and meta-analysis
by: Yicheng Guo, et al.
Published: (2025-03-01)

The imidazoline receptors and the central regulation of the arterial blood pressure: a minireview
by: Eduardo Tibiriça, et al.
Published: (1993-06-01)

Indirect involvement of α2-adrenoceptors in the mechanical antihypersensitivity effect induced by the spinally administered imidazoline I1 receptor ligand LNP599 in a rat model of experimental neuropathy
by: Hong Wei, et al.
Published: (2024-10-01)

Methoxyphenyl Imidazolines as Potential Activators of p53
by: Daniil R. Bazanov, et al.
Published: (2022-11-01)

Ligands of Adrenergic Receptors: A Structural Point of View
by: Yiran Wu, et al.
Published: (2021-06-01)

Dexmedetomidine as a Cardioprotector in Cardiac Surgery (Review)
by: I. A. Kozlov, et al.
Published: (2017-09-01)

PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
by: Santosh Reddy Alluri, et al.
Published: (2020-09-01)

β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe?
by: Abrahim Mahmood, et al.
Published: (2022-07-01)

Physiology and pharmacology of cardiovascular adrenergic system
by: Anastasios eLymperopoulos
Published: (2013-09-01)